{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:30:20Z","timestamp":1783398620632,"version":"3.54.6"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T00:00:00Z","timestamp":1438128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00105-015-3659-0","type":"journal-article","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T08:40:48Z","timestamp":1438072848000},"page":"604-610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Dermatomyositis \u2013 update","Dermatomyositis\u2014update"],"prefix":"10.1007","volume":"66","author":[{"given":"B.","family":"Volc-Platzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,29]]},"reference":[{"key":"3659_CR1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11926-009-0042-0","volume":"11","author":"R Adler","year":"2009","unstructured":"Adler R, Garofalo G (2009) Ultrasound in the evaluation of the inflammatory myopathies. Curr Rheumatol Rep 11:302\u2013308","journal-title":"Curr Rheumatol Rep"},{"key":"3659_CR2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/BOR.0b013e328358ac72","volume":"24","author":"R Aggarwal","year":"2012","unstructured":"Aggarwal R, Oddis CV (2012) Therapeutic advances in myositis. Curr Opin Rheumatol 24:635\u2013641","journal-title":"Curr Opin Rheumatol"},{"key":"3659_CR3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22477","volume":"70","author":"Amato AA for the Muscle Study Group","year":"2011","unstructured":"Amato AA for the Muscle Study Group (2011) A randomized, pilot trial of Etanercept in dermatomyositis. Ann Neurol 70:427\u2013436","journal-title":"Ann Neurol"},{"key":"3659_CR4","first-page":"835","volume":"141","author":"GC Ang","year":"2005","unstructured":"Ang GC, Werth VP (2005) Combination antimalarials in the treatment of 7cutaneous dermatomyositis. Arch Dermatol 141:835\u2013839","journal-title":"Arch Dermatol"},{"key":"3659_CR5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/ar3531","volume":"13","author":"EC Baechler","year":"2011","unstructured":"Baechler EC, Bilgic H, Reed AM (2011) Type I interferon pathway in adult and juvenile dermatomyositis. Arthr Res Ther 13:249","journal-title":"Arthr Res Ther"},{"key":"3659_CR6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","volume":"146","author":"MJ Bendelwald","year":"2010","unstructured":"Bendelwald MJ, Wetter DA, Xujian L, Davis MDP (2010) Incidence of dermatomyositis and clinically amyopathic dermatomyositis. Arch Dermatol 146:26\u201330","journal-title":"Arch Dermatol"},{"key":"3659_CR7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344\u2013347 (und 403\u2013407)","journal-title":"N Engl J Med"},{"key":"3659_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","volume":"355","author":"JP Callen","year":"2000","unstructured":"Callen JP (2000) Dermatomyositis. Lancet 355:53\u201357","journal-title":"Lancet"},{"key":"3659_CR9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cei.12194","volume":"175","author":"PO Carstens","year":"2014","unstructured":"Carstens PO, Schmidt J (2014) Diagnosis, pathogenesis and treatment of myositis: recent advances. Clin Exp Immunol 175:349\u2013358","journal-title":"Clin Exp Immunol"},{"key":"3659_CR10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/BOR.0b013e328358bd85","volume":"24","author":"L Casciola Rosen","year":"2012","unstructured":"Casciola Rosen L, Mammen AL (2012) Myositis autoantibodies. Curr Opin Rheumatol 24:602\u2013608","journal-title":"Curr Opin Rheumatol"},{"key":"3659_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2009.04386.x","volume":"1154","author":"RV Curiel","year":"2009","unstructured":"Curiel RV, Jones R, Brindle K (2009). Magnetic resonance imaging for idiopathic inflammatory myopathies: structural and clinical aspects. Ann NY Acad Sci 1154:101\u2013114","journal-title":"Ann NY Acad Sci"},{"key":"3659_CR12","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM et al (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993\u20132000","journal-title":"N Engl J Med"},{"key":"3659_CR13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2010.09.004","volume":"10","author":"MG Danieli","year":"2011","unstructured":"Danieli MG, Pettinari L, Moretti R et al (2011) Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. Autoimmun Rev 10:144\u2013149","journal-title":"Autoimmun Rev"},{"key":"3659_CR14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1684\/ejd.2008.0580","volume":"19","author":"A Enk","year":"2009","unstructured":"Enk A, the European Dermatology Forum Guideline Subcommittee (2009) Guidelines on the use of high-dose intravenous immunoglobulin in dermatology. Eur J Dermatol 19:90\u201398","journal-title":"Eur J Dermatol"},{"key":"3659_CR15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0190-9622(91)70153-S","volume":"24","author":"RL Euwer","year":"1991","unstructured":"Euwer RL, Sontheimer RB (1991) Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review oft he literature. J Am Acad Dermatol 24:959\u2013966","journal-title":"J Am Acad Dermatol"},{"key":"3659_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MD.0b013e31827ebba1","volume":"92","author":"C Fernandez","year":"2013","unstructured":"Fernandez C, Bardin N, Maues De, Paula A et al (2013) Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies. Medicine 92:15\u201324","journal-title":"Medicine"},{"key":"3659_CR17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s002560000238","volume":"29","author":"J Garcia","year":"2000","unstructured":"Garcia J (2000) MRI in inflammatory myopathies. Skeletal Radiol 29:425\u2013438","journal-title":"Skeletal Radiol"},{"key":"3659_CR18","first-page":"29","volume":"10","author":"I G\u00f6ttfried","year":"2000","unstructured":"G\u00f6ttfried I, Seeber A, Anegg B et al (2000) High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels. Eur J Dermatol 10:29\u201335","journal-title":"Eur J Dermatol"},{"key":"3659_CR19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11926-010-0101-6","volume":"12","author":"SA Greenberg","year":"2010","unstructured":"Greenberg SA et al (2010) Dermatomyositis and type 1 interferons. Curr Rheumatol Rep 12:198\u2013203","journal-title":"Curr Rheumatol Rep"},{"key":"3659_CR20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0190-9622(91)70186-6","volume":"25","author":"G Hausmann","year":"1991","unstructured":"Hausmann G, Herrero C, Cid MC et al (1991) Immunopathologic study of skin lesions in dermatomyositis. J Am Acad Dermatol 25:225\u2013230","journal-title":"J Am Acad Dermatol"},{"key":"3659_CR21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/annrheumdis-2012-202794","volume":"73","author":"BW Higgs","year":"2013","unstructured":"Higgs BW, Zhu W, Morehouse C et al (2013) A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-a monoclonal antibody, shows target neutralisation of a type I signature in blood of dermatomyositis and polymyositis patients. Ann Rheum Dis 73:256\u2013262","journal-title":"Ann Rheum Dis"},{"key":"3659_CR22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhanf Y, Sigurgeirrson B et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96\u2013100","journal-title":"Lancet"},{"key":"3659_CR23","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1056\/NEJMc1412997","volume":"371","author":"T Hornung","year":"2014","unstructured":"Hornung T, Janzen V, Wenzel J (2014) Remission of recalcitrant dermatomyositis treated with Ruxolitinib. N Engl J Med 371:2537\u20132538","journal-title":"N Engl J Med"},{"key":"3659_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaad.2008.02.043","volume":"59","author":"LJ Jorizzo","year":"2008","unstructured":"Jorizzo LJ, Jorizzo JI (2008) The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol 59:99\u2013112","journal-title":"J Am Acad Dermatol"},{"key":"3659_CR25","doi-asserted-by":"crossref","first-page":"S489","DOI":"10.1002\/art.10125","volume":"46","author":"T Kazuki","year":"2002","unstructured":"Kazuki T, Bookbinder S, Furie R (2002) A \u00fcilot study of eculizumab in patients with dermatomyositis. Arthritis Res 46:S489","journal-title":"Arthritis Res"},{"key":"3659_CR26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5021\/ad.2011.23.3.348","volume":"23","author":"JE Kim","year":"2011","unstructured":"Kim JE, Jeong MG, Lee HE et al (2011) Successful treatment of cutaneous lesions of dermatomyositis with topical pimecrolimus. Ann Dermatol 23:348\u2013351","journal-title":"Ann Dermatol"},{"key":"3659_CR27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","volume":"314","author":"JT Kissel","year":"1986","unstructured":"Kissel JT, Mendell JR, Rammohan KW (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 314:329\u2013334","journal-title":"N Engl J Med"},{"key":"3659_CR28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(98)70263-4","volume":"39","author":"SO Kovacs","year":"1998","unstructured":"Kovacs SO, Kovacs C (1998) Dermatomyositis. J Am Acad Dermatol 39:899\u2013920","journal-title":"J Am Acad Dermatol"},{"key":"3659_CR29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/DDDT.S33110","volume":"6","author":"T Levine","year":"2012","unstructured":"Levine T (2012) Treating refractory dermatomyositis and polymyositis with adrenocorticotropic hormine gel: a retrospective case series. Drug Des Devel Ther 6:133\u2013139","journal-title":"Drug Des Devel Ther"},{"key":"3659_CR30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogenous patient groups. Medicine 70:360\u2013374","journal-title":"Medicine"},{"key":"3659_CR31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0560.2007.00770.x","volume":"35","author":"CM Magro","year":"2008","unstructured":"Magro CM, Dyrsen M., Kerns MJ (2008) Cutaneous lesions of dermatomyositis with supervening fibrosis. J Cutan Pathol 35:31\u201339","journal-title":"J Cutan Pathol"},{"key":"3659_CR32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/ar4116","volume":"14","author":"V Malmstr\u00f6m","year":"2012","unstructured":"Malmstr\u00f6m V, Venalis P, Albrecht I (2012) T cells in myositis. Arthritis Res Ther 14:230\u2013236","journal-title":"Arthritis Res Ther"},{"key":"3659_CR33","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archderm.1995.01690240040007","volume":"131","author":"JM Mascaro Jr","year":"1995","unstructured":"Mascaro JM Jr, Hausmann G, Herrero C et al (1995) Membrane attack complex deposits in cutaneous lesions of dermatomyositis. Arch Dermatol 131:1386\u20131392","journal-title":"Arch Dermatol"},{"key":"3659_CR34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/RHU.0000000000000062","volume":"20","author":"T Mathur","year":"2014","unstructured":"Mathur T, Manadan AM, Thiagarajan S et al (2014) The utility of serum aldolase in normal creatine kinase dermatomyositis. J Clin Rheumatol 20:47\u201348","journal-title":"J Clin Rheumatol"},{"key":"3659_CR35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","volume":"45","author":"LJ McCann","year":"2006","unstructured":"McCann LJ, Juggins AD, Maillard SM et al (2006) The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) \u2013 clinical characteristics of children recruited within the first 5 yr. Rheumatology 45:1255\u20131260","journal-title":"Rheumatology"},{"key":"3659_CR36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"EP Mendez","year":"2003","unstructured":"Mendez EP, Lipton R, Ramsey-Goldman R et al (2003) US Incidence of juvenile dermatomyositis. 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 49:300\u2013305","journal-title":"Arthritis Rheum"},{"key":"3659_CR37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","volume":"54","author":"A Meyer","year":"2015","unstructured":"Meyer A, Meyer N, Schaeffer M et al (2015) Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology 54:50\u201363","journal-title":"Rheumatology"},{"key":"3659_CR38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis CV, Reed AM, Aggarwal R et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase Trial. Arthritis Rheum 65:314\u2013324","journal-title":"Arthritis Rheum"},{"key":"3659_CR39","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3899\/jrheum.140626","volume":"42","author":"A Peter","year":"2015","unstructured":"Peter A, Balogh A, Szilagyi S et al (2015) Echocardiographic abnormalities in new-onset polymyositis\/dermatomyositis. J Rheumatol 42:272\u2013281","journal-title":"J Rheumatol"},{"key":"3659_CR40","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","volume":"23","author":"S Sato","year":"2013","unstructured":"Sato S, Kuwana M, Fuijita T et al (2013) Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol 23:496\u2013502","journal-title":"Mod Rheumatol"},{"key":"3659_CR41","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.rmed.2011.05.006","volume":"105","author":"K Tanizawa","year":"2011","unstructured":"Tanizawa K, Handa T, Nakashima R et al (2011) HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Resp Med 105:1380\u20131387","journal-title":"Resp Med"},{"key":"3659_CR42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MD.0000000000000222","volume":"93","author":"Y Troyanov","year":"2014","unstructured":"Troyanov Y, Targoff IN, Payette M-P et al (2014) Redefining Dermatomyositis. A description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine 93:318\u2013332","journal-title":"Medicine"},{"key":"3659_CR43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2133.2003.05209_4.x","volume":"148","author":"M Ueda","year":"2003","unstructured":"Ueda M, Makinodan R, Matsumura M, Ichihashi M (2003) Successful treatment of amyopathic dermatomyositis with topical tacrolimus. Br J Dermtol 148:595\u2013596","journal-title":"Br J Dermtol"},{"key":"3659_CR44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/rheumatology\/37.2.196","volume":"37","author":"GF Wiesinger","year":"1998","unstructured":"Wiesinger GF, Quittan M, Aringer M et al (1998) Improvement of physical fitness and muscle strength in polymyositis\/dermatomyositis patients by a training programme. Br J Rheumatol 37:196\u2013200","journal-title":"Br J Rheumatol"},{"key":"3659_CR45","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/annrheumdis-2011-200564","volume":"71","author":"A Winklehner","year":"2012","unstructured":"Winklehner A, Berger N, Maurer B et al (2012) Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices. Ann Rheum Dis 71:549\u2013552","journal-title":"Ann Rheum Dis"},{"key":"3659_CR46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11926-011-0169-7","volume":"13","author":"ZE Zahr","year":"2011","unstructured":"Zahr ZE, Baer AN (2011) Malignancy in myositis. Curr Rheumatol Rep 13:208\u2013215","journal-title":"Curr Rheumatol Rep"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-015-3659-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-015-3659-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-015-3659-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T06:50:50Z","timestamp":1718002250000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-015-3659-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,29]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3659"],"URL":"https:\/\/doi.org\/10.1007\/s00105-015-3659-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,29]]}}}